These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 1455866

  • 21. The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update.
    Chang J, Morgenstern GR, Coutinho LH, Scarffe JH, Carr T, Deakin DP, Testa NG, Dexter TM.
    Bone Marrow Transplant; 1989 Jan; 4(1):5-9. PubMed ID: 2647188
    [Abstract] [Full Text] [Related]

  • 22. Association between the secondary colony-plating efficiency of blast progenitors and the remission induction outcome of acute myeloblastic leukemia patients.
    Nara N.
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1624-9. PubMed ID: 3247826
    [No Abstract] [Full Text] [Related]

  • 23. What's up with down syndrome and leukemia-A lot!
    Taub JW, Ravindranath Y.
    Pediatr Blood Cancer; 2011 Jul 15; 57(1):1-3. PubMed ID: 21480471
    [No Abstract] [Full Text] [Related]

  • 24. Second long-term remission achieved with low-dose Ara-C in children with relapsed acute nonlymphoblastic leukemia.
    Miniero R, Saracco P, Cordero di Montezemolo L, Fiandino G, Comelli A, Madon E.
    Pediatr Hematol Oncol; 1987 Jul 15; 4(3):273-6. PubMed ID: 3152932
    [No Abstract] [Full Text] [Related]

  • 25. Etoposide in remission induction of adult acute myeloid leukemia.
    Leoni F, Ciolli S, Patriarchi S, Morfini M, Rossi Ferrini P.
    Acta Haematol; 1990 Jul 15; 83(2):82-5. PubMed ID: 2106200
    [Abstract] [Full Text] [Related]

  • 26. Trisomy 21 as a sole acquired abnormality in an adult Omani patient with CD7- and CD9-positive acute myeloid leukemia.
    Udayakumar AM, Pathare AV, Muralitharan S, Alghzaly AA, Alkindi S, Raeburn JA.
    Arch Med Res; 2007 Oct 15; 38(7):797-802. PubMed ID: 17845902
    [Abstract] [Full Text] [Related]

  • 27. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May 15; 18(3):192-8. PubMed ID: 4517790
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
    Reinhardt D, Hempel G, Fleischhack G, Schulz A, Boos J, Creutzig U.
    Klin Padiatr; 2002 May 15; 214(4):188-94. PubMed ID: 12165900
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML).
    Battipaglia G, Avilia S, Morelli E, Caranci F, Perna F, Camera A.
    Ann Hematol; 2012 Aug 15; 91(8):1327-8. PubMed ID: 22237936
    [No Abstract] [Full Text] [Related]

  • 32. High-dose Ara-C as a single-agent consolidation therapy in childhood acute myelogenous leukemia.
    Lie SO, Berglund G, Gustafsson G, Jonmundsson G, Siimes M, Yssing M.
    Haematol Blood Transfus; 1990 Aug 15; 33():215-21. PubMed ID: 2138994
    [No Abstract] [Full Text] [Related]

  • 33. [Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols].
    Creutzig U, Ritter I, Schellong G.
    Gematol Transfuziol; 1991 Jan 15; 36(1):16-21. PubMed ID: 2065939
    [No Abstract] [Full Text] [Related]

  • 34. Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factors.
    Weinstein H, Grier H, Gelber R, Camitta B, Link M, Delorey M, Price K.
    Haematol Blood Transfus; 1987 Jan 15; 30():88-92. PubMed ID: 3476388
    [No Abstract] [Full Text] [Related]

  • 35. Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985.
    Marcus RE, Catovsky D, Prentice HG, Newland AC, Chessells JM, Stevens RF, Hann IM, Goldman JM, Hoffbrand AV, Galton DA.
    Haematol Blood Transfus; 1987 Jan 15; 30():346-51. PubMed ID: 2442074
    [No Abstract] [Full Text] [Related]

  • 36. Therapy of acute myelogenous leukemia in adults.
    Petti MC, Broccia G, Caronia F, Di Raimondo F, Fioritoni G, Ladogana S, Leone G, Liso V, Musso M, Neri A.
    Haematol Blood Transfus; 1990 Jan 15; 33():249-53. PubMed ID: 2182417
    [No Abstract] [Full Text] [Related]

  • 37. Preliminary results of intensive therapy of children and adolescents with acute nonlymphocytic leukemia--a Childrens Cancer Study Group report.
    Lampkin BC, Woods WG, Buckley JD, Hammond GD.
    Haematol Blood Transfus; 1990 Jan 15; 33():210-4. PubMed ID: 1691130
    [No Abstract] [Full Text] [Related]

  • 38. The ninth British Medical Research Council trial for the treatment of acute myeloid leukaemia.
    Rees JK, Gray R, Hayhoe FG.
    Haematol Blood Transfus; 1987 Jan 15; 30():35-7. PubMed ID: 2442075
    [No Abstract] [Full Text] [Related]

  • 39. Myxoedema in a case of acute myeloid leukaemia.
    Grützmeier S.
    Scand J Haematol; 1985 Apr 15; 34(4):323-5. PubMed ID: 3858981
    [Abstract] [Full Text] [Related]

  • 40. Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.
    Witteveen EO, Verdonck LF, Nieuwenhuis HK, Dekker AW.
    Haematol Blood Transfus; 1990 Apr 15; 33():309-13. PubMed ID: 2323635
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.